SCINAI IMMUNOTHERAPEUTICS LTD. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $304.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-04-01
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|
| 2025-12-31 | $304.00K 20-F · filed 2026-04-01 | |
| 2024-12-31 | $682.00K 20-F · filed 2026-04-01 | |
| 2024-06-30 | $333.00K 6-K · filed 2024-09-09 | |
| 2023-12-31 | $869.00K 20-F · filed 2026-04-01 | |
| 2023-06-30 | $459.00K 6-K · filed 2024-09-09 | |
| 2022-12-31 | $1.60M 20-F · filed 2025-05-07 |